65 related articles for article (PubMed ID: 1170394)
1. [Clinical significance of anti-HBc (core antibody) in B type hepatitis].
Fujita K; Ichida F; Mayumi M; Tsuda F; Takahashi T
Nihon Rinsho; 1975 Feb; 33(2):463-6. PubMed ID: 1170394
[No Abstract] [Full Text] [Related]
2. [Incidence of antibody against hepatitis B core antigen (anti-HBc) in chronic diffuse liver diseases].
Dávid K; Halmy L
Orv Hetil; 1983 Apr; 124(15):879-84. PubMed ID: 6856288
[No Abstract] [Full Text] [Related]
3. [The incidence of serum anti-HBc and anti-HBs and tissue HBcAg in patients with HBsAg-negative hepatopathy].
Giuliani-Piccari G; Orlandi G; Roccuzzo S; D'Imperio N; Formica G; Piemontese A; Sarti F
G Clin Med; 1981 Feb; 62(2):94-102. PubMed ID: 7239059
[No Abstract] [Full Text] [Related]
4. [Clinical relevance of immunoglobulin M antibody fraction against hepatitis B core antigen (anti-HBc-IgM) (author's transl)].
Feuerhake A; Wille E; Müller R
Dtsch Med Wochenschr; 1982 Jul; 107(26):1012-4. PubMed ID: 7084068
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of immunoglobulin A antibody to hepatitis B core antigen of polymeric and monomeric forms in chronic type B liver disease with acute exacerbation.
Nomura M; Douchin M; Tokuda A; Sato F; Ito S; Kohli Y; Fujiki N
Am J Gastroenterol; 1988 Dec; 83(12):1390-4. PubMed ID: 3195545
[TBL] [Abstract][Full Text] [Related]
6. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
Dávid K; Halmy L
Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
[TBL] [Abstract][Full Text] [Related]
7. Anti-HBc titers and anti-HBc immunoglobulin (M/G) classes in acute, chronic and resolved hepatitis B.
Niermeijer P; Gips CH; Huizenga JR; Houthoff HJ; Snijder JA
Hepatogastroenterology; 1980 Aug; 27(4):271-6. PubMed ID: 7203363
[TBL] [Abstract][Full Text] [Related]
8. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen.
Marusawa H; Uemoto S; Hijikata M; Ueda Y; Tanaka K; Shimotohno K; Chiba T
Hepatology; 2000 Feb; 31(2):488-95. PubMed ID: 10655275
[TBL] [Abstract][Full Text] [Related]
9. Letter: Behaviour of e antigen and antibody during chronic active liver disease.
Vogten AJ; Summerskill WH
Lancet; 1976 Sep; 2(7985):577. PubMed ID: 60654
[No Abstract] [Full Text] [Related]
10. [Antinuclear antibody (anti-HBc) and liver pathology in acute and chronic virus B hepatitis].
Dentico P; Pastore G; Buongiorno R; Angarano G; Lapedota E; Schiraldi O
Boll Soc Ital Biol Sper; 1979 Jul; 55(12):1141-6. PubMed ID: 317942
[TBL] [Abstract][Full Text] [Related]
11. Correlation between titer of antibody to hepatitis B core antigen and presence of viral antigens in the liver.
Kojima M; Udo K; Takahashi Y; Yoshizawa H; Tsuda F; Itoh Y; Miyakawa Y; Mayumi M
Gastroenterology; 1977 Oct; 73(4 Pt 1):664-7. PubMed ID: 330306
[TBL] [Abstract][Full Text] [Related]
12. Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals.
Gandhi RT; Wurcel A; Lee H; McGovern B; Boczanowski M; Gerwin R; Corcoran CP; Szczepiorkowski Z; Toner S; Cohen DE; Sax PE; Ukomadu C
Clin Infect Dis; 2003 Jun; 36(12):1602-5. PubMed ID: 12802762
[TBL] [Abstract][Full Text] [Related]
13. Anti-hepatitis B core antibody is not required for prevaccination screening in healthcare workers.
Shim J; Kim KY; Kim BH; Chun H; Lee MS; Hwangbo Y; Jang JY; Dong SH; Kim HJ; Chang YW; Chang R
Vaccine; 2011 Feb; 29(8):1721-6. PubMed ID: 21147128
[TBL] [Abstract][Full Text] [Related]
14. Isolated antibody to hepatitis B core antigen in individuals infected with HIV-1.
Hung CC; Hsiao CF
Clin Infect Dis; 2003 Nov; 37(9):1275-6;; author reply 1277. PubMed ID: 14557978
[No Abstract] [Full Text] [Related]
15. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C
J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiological study on carriers of hepatitis-B surface anti-antigens antibodies].
Franco E; Giorgetta P; Taliani G; Chircu LV; Mattiacci M
Boll Soc Ital Biol Sper; 1975 Nov; 51(21):1545-7. PubMed ID: 1231839
[No Abstract] [Full Text] [Related]
17. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
[TBL] [Abstract][Full Text] [Related]
18. Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients.
Neau D; Winnock M; Galpérine T; Jouvencel AC; Castéra L; Legrand E; Tranchant E; Balestre E; Lacoste D; Ragnaud JM; Dupon M; Lafon ME; Dabis F;
HIV Med; 2004 May; 5(3):171-3. PubMed ID: 15139983
[TBL] [Abstract][Full Text] [Related]
19. Exposure to hepatitis B virus in the general population of Hisayama, Japan: significance of isolated antibody to hepatitis B surface antigen in general population.
Kajiwara E; Akagi K; Ueda K; Murai K; Hasuo Y; Kiyohara Y; Wada J; Kawano H; Kato I; Fujishima M
Fukuoka Igaku Zasshi; 1992 Jun; 83(6):250-6. PubMed ID: 1511950
[TBL] [Abstract][Full Text] [Related]
20. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
